The end of fasting before contrast-enhanced computed tomography? A prospective study in adults

Not Applicable

Completed

• Conditions: ausea after non-ionic intravenous contrast administration; Vomiting after non-ionic intravenous contrast administration; Nausea after non-ionic intravenous contrast administration; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12623000071628
• Lead Sponsor: Fundación para la Investigación Biosanitaria en Andalucía Oriental (FIBAO)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-23
• Study Completion: 2023-01-31
• Last Update Posted: 13 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1148

Inclusion Criteria

Patients must be scheduled for a non-emergency contrast-enhanced CT scan during weekdays and be equal to or older than 18 years in order to participate in the study.

Exclusion Criteria

Incomplete form data filling, presence of intravenous contrast extravasation, intake of antiemetic and prokinetic medication 8 to 12 hours before the examination, patients with overt hyperthyroidism, history of allergic reaction or hypersensitivity to iodinated contrast media and patients unable to provide written informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence, timing, and severity of adverse reactions (e.g. nausea, vomiting) after administration of intravenous non-ionic contrast media assessed using a record sheet self-designed by our group.[15 and 30 minutes following intravenous injection of contrast media agent. ]

Secondary Outcome Measures

Name	Time	Method
il[Nil ]